Skip to main content

FDA Approvals

Payers' Guide, FDA Approvals
Linzess: A Novel Treatment Option for Constipation Associated with Irritable Bowel Syndrome
Alice Goodman, Medical Writer
Read More
Payers' Guide, FDA Approvals
Perjeta: A New Option for Patients with HER2-Positive Metastatic Breast Cancer
Alice Goodman, Medical Writer
Read More
FDA Approvals, Payers' Guide
Trends in the 2013 Pharmaceutical Pipeline
Dalia Buffery, MA, ABD, Atheer A. Kaddis, PharmD
Read More
Payers' Guide, FDA Approvals
Iclusig: A New Treatment Option for Adults with CML or Ph+ ALL that Is Resistant/ Intolerant to Previous Therapy with TKIs
Lynne Lederman, PhD, Medical Writer
Read More
Payers' Guide, FDA Approvals
Qsymia: Combination Oral Therapy a New Weight-Loss Option for Obese or Overweight Patients
Loretta Fala
Read More
Payers' Guide, FDA Approvals
Rayos: A Novel Oral Delayed-Release Prednisone for the Treatment of Rheumatoid Arthritis and Other Inflammatory Diseases
Alice Goodman, Medical Writer
Read More
Payers' Guide, FDA Approvals
Xeljanz: A New Treatment Option for Patients with Rheumatoid Arthritis
Alice Goodman, Medical Writer
Read More
Payers' Guide, FDA Approvals
Tudorza Pressair: A Novel Oral Inhalation Therapy for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease–Associated Bronchospasm
Loretta Fala
Read More
Payers' Guide, FDA Approvals
Vascepa: First EPA-Only Omega-3 Therapy Approved by the FDA for Severe Hypertriglyceridemia
Loretta Fala
Read More
Payers' Guide, FDA Approvals
Eliquis Approved by the FDA to Reduce the Risks of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
Loretta Fala
Read More
Page 48 of 53
Results 471 - 480 of 525